Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
Zuraw B, Lumry WR, Johnston DT, Aygören-Pürsün E, Banerji A, Bernstein JA, Christiansen SC, Jacobs JS, Sitz KV, Gower RG, Gagnon R, Wedner HJ, Kinaciyan T, Hakl R, Hanzlíková J, Anderson JT, McNeil DL, Fritz SB, Yang WH, Tachdjian R, Busse PJ, Craig TJ, Li HH, Farkas H, Best JM, Clemons D, Cornpropst M, Dobo SM, Iocca HA, Kargl D, Nagy E, Murray SC, Collis P, Sheridan WP, Maurer M, Riedl MA. Zuraw B, et al. Among authors: hakl r. J Allergy Clin Immunol. 2021 Jul;148(1):164-172.e9. doi: 10.1016/j.jaci.2020.10.015. Epub 2020 Oct 21. J Allergy Clin Immunol. 2021. PMID: 33098856 Free article. Clinical Trial.
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
Riedl MA, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M. Riedl MA, et al. Among authors: hakl r. Lancet. 2017 Sep 30;390(10102):1595-1602. doi: 10.1016/S0140-6736(17)31963-3. Epub 2017 Jul 25. Lancet. 2017. PMID: 28754491 Clinical Trial.
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema.
Valerieva A, Staevska M, Jesenak M, Hrubiskova K, Sobotkova M, Zachova R, Hakl R, Andrejevic S, Suiter T, Grivcheva-Panovska V, Karadza-Lapic L, Soteres D, Shapiro R, Rumbyrt J, Tachdjian R, Mehta V, Hsu FI, Zanichelli A. Valerieva A, et al. Among authors: hakl r. J Allergy Clin Immunol Pract. 2020 Feb;8(2):799-802. doi: 10.1016/j.jaip.2019.08.011. Epub 2019 Aug 19. J Allergy Clin Immunol Pract. 2020. PMID: 31437566 Free article. No abstract available.
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema.
Germenis AE, Margaglione M, Pesquero JB, Farkas H, Cichon S, Csuka D, Lera AL, Rijavec M, Jolles S, Szilagyi A, Trascasa ML, Veronez CL, Drouet C, Zamanakou M; Hereditary Angioedema International Working Group. Germenis AE, et al. J Allergy Clin Immunol Pract. 2020 Mar;8(3):901-911. doi: 10.1016/j.jaip.2019.10.004. Epub 2019 Oct 24. J Allergy Clin Immunol Pract. 2020. PMID: 31669336 Review.
Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients.
Sobotkova M, Zachova R, Hakl R, Kuklinek P, Kralickova P, Krcmova I, Hanzlikova J, Vachova M, Bartunkova J. Sobotkova M, et al. Among authors: hakl r. Int Arch Allergy Immunol. 2021;182(7):642-649. doi: 10.1159/000512933. Epub 2021 Jan 20. Int Arch Allergy Immunol. 2021. PMID: 33472202 Free PMC article.
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
Valerieva A, Staevska MT, Grivcheva-Panovska V, Jesenak M, Kőhalmi KV, Hrubiskova K, Zanichelli A, Bellizzi L, Relan A, Hakl R, Farkas H. Valerieva A, et al. Among authors: hakl r. World Allergy Organ J. 2021 Apr 22;14(4):100535. doi: 10.1016/j.waojou.2021.100535. eCollection 2021 Apr. World Allergy Organ J. 2021. PMID: 33995818 Free PMC article.
23 results